Immix Biopharma, Inc. IMMX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s common stock, par value (in dollars per share)?
- Immix Biopharma, Inc. (IMMX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Immix Biopharma, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Immix Biopharma, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Immix Biopharma, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.